Global Retirement Partners’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Global Retirement Partners’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5	Closed	-$971	–	3274
2023 Q1	$971	Buy	5 +2	+67%	+$230	﹤0.01%	2741
2022 Q4	$330	Buy	+3	New	+$195	﹤0.01%	2849

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Global Retirement Partners's RXDX Position: Q2 2023 in Review

Global Retirement Partners sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 5 shares — an estimated $971 sold.

Global Retirement Partners first reported a position in RXDX in Q4 2022 and held it in 2 quarters. The position peaked at $971 in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Global Retirement Partners reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Global Retirement Partners sold 5 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $971.
Global Retirement Partners first reported a position in Prometheus Biosciences, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Global Retirement Partners's Prometheus Biosciences, Inc. Common Stock position peaked at $971 in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Global Retirement Partners's 13F filing for Q2 2023, filed 20 Jul 2023.